Free Trial
→ Trump’s Sending THIS Crypto Higher on Purpose (From Crypto 101 Media) (Ad) Free CNCR Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.

Range Cancer Therapeutics ETF (CNCR) Dividend Yield, Date & History

Compare

Range Cancer Therapeutics ETF Dividend Summary

Dividend Yield
2.40%
Annual Dividend
$0.29
Recent
Dividend Payment
Dec. 31

Range Cancer Therapeutics ETF (CNCR) pays an annual dividend of $0.29 per share, with a dividend yield of 2.40%. The next annual payment of $1.8530 per share was paid on Friday, December 31, to investors who owned the stock before the ex-dividend date of Wednesday, December 29.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
Skip Charts & View Dividend History

CNCR Dividend Payments by Quarter

The chart below displays up to four years of Range Cancer Therapeutics ETF's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

CNCR Dividend Yield Over Time

The chart below tracks Range Cancer Therapeutics ETF's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

Range Cancer Therapeutics ETF vs. The Competition

Compare Range Cancer Therapeutics ETF's annual dividend, yield, and 3-year growth rate with averages for and NASDAQ companies to evaluate its performance against the market.

TypeRange Cancer Therapeutics ETF CompaniesNASDAQ Companies
Annual Dividend$0.29$0.01$1.31
Dividend Yield2.40%14.47%4.23%
Annualized 3-Year Dividend Growth0.00%33.61%14.22%

Range Cancer Therapeutics ETF Dividend History by Quarter

There are no dividend announcements in the selected date range. Select a different date range.

This table shows Range Cancer Therapeutics ETF's annualdividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

Range Cancer Therapeutics ETF Dividend - Frequently Asked Questions

The current dividend yield for Range Cancer Therapeutics ETF is 2.40%. Learn more on CNCR's dividend yield history.

The annual dividend for CNCR shares is $0.29. Learn more on CNCR's annual dividend history.

Range Cancer Therapeutics ETF pays annual dividends to shareholders.

Range Cancer Therapeutics ETF's most recent annual dividend payment of $1.8530 per share was made to shareholders on Friday, December 31, 2021.

Range Cancer Therapeutics ETF's most recent ex-dividend date was Wednesday, December 29, 2021.

The most recent change in the company's dividend was an increase of $1.5650 on Tuesday, December 28, 2021.

Related Companies
Dividend Tools
Stock Lists
Latest Articles

This page (NASDAQ:CNCR) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners
This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...
Banyan Hill Publishing | Sponsored
WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...
Behind the Markets | Sponsored
Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average A...
MyBankTracker | Sponsored
Rare "crisis signal" triggers for third time in U.S. market
A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...
Stansberry Research | Sponsored
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...
Porter & Company | Sponsored
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...
Brownstone Research | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Altcoin season moves fast, and those who hesitate are left behind. The window is closing.
Crypto Swap Profits | Sponsored